; (B) labels or advertises one or more in vitro clinical tests with false or misleading claims; or (C) is no longer an eligible person under subsection (b)(1). (j) Withdrawal The Secretary may, after due notice and opportunity for informal hearing, issue an order withdrawing a technology certification order if the Secretary finds that— (1) the application, supplement, or report under subsection (e) or (g) contains false or misleading information or fails to reveal a material fact; (2) such holder fails to correct false or misleading labeling or advertising upon the request of the Secretary; (3) in connection with a technology certification, the holder provides false or misleading information to the Secretary; or (4) the holder of such technology certification order fails to correct the grounds for temporary hold within a timeframe specified in the temporary hold order. (k) Reports to Congress (1) In general Not later than one year after the effective date, and annually for 4 years thereafter, the Secretary shall prepare and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate, and make publicly available, including through posting on the internet website of the Food and Drug Administration, a report containing the information required under paragraph (2). (2) Content (A) In general Each report under paragraph (1) shall address, at a minimum— (i) the total number and type of applications for technology certifications filed, granted, withdrawn or denied; (ii) the total number of technology certification orders put on temporary hold under subsection (i) and the number of technology certification orders withdrawn under subsection (j); (iii) the types of technologies for which technology certification orders were granted